ANN ARBOR, Mich., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the RHK Capital 2019 Disruptive Growth Conference on September 4, as well as the Fall Investor Summit on September 16 and the Sidoti & Company Fall 2019 Investor Conference on September 25.

Chief Financial Officer Shameze Rampertab, CPA, CA, will provide an overview of Zomedica’s business during his presentations at the conferences and will be available to participate in one-on-one meetings with registered investors.

RHK Capital 2019 Disruptive Growth Conference
Date: Wednesday, September 4
Time: 4:20 p.m. EDT
Location: Reed Smith, New York, NY

Fall Investor Summit
Date: Monday, September 16
Time: 2:00 p.m. EDT
Location: The Essex House, New York, NY  

Sidoti & Company Fall 2019 Investor Conference
Date: Wednesday, September 25
Time: 3:20 p.m. EDT
Location: Grand Hyatt NYC, New York, NY  

Investors and other interested parties will be able to access live webcasts of the presentations by visiting Zomedica’s website at http://investors.zomedica.com. A replay of the audio webcasts and presentations will be accessible on the Zomedica website following the events.

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) (TSX-V: ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline, and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica
• Facebook: https://www.facebook.com/zomedica/
• Twitter: https://twitter.com/zomedica

Reader Advisory
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

Investor Relations Contact
Shameze Rampertab, CPA, CA
srampertab@zomedica.com
+1 647.283.3630

PCG Advisory Group
Kirin Smith, COO
ksmith@pcgadvisory.com
+1 646.863.6519

Media Contact
Christy Penka
cpenka@zomedica.com
+1 734.369.2555